VG Life Sciences Inc. balance sheet BIOM

Annual Quarterly

As of Sep 30, 2015, VG Life Sciences Inc. had total assets of $1.1 million. Total assets were down 1.8% from a year earlier. Stockholders' equity was negative, at -$4.3 million, because liabilities exceed assets. Cash and investments were $22,919. The current ratio, current assets divided by current liabilities, was 0.01.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Q3 FY2015
Sep 30, 2015
Q2 FY2015
Jun 30, 2015
Q1 FY2015
Mar 31, 2015
Q4 FY2014
Dec 31, 2014
Q3 FY2014
Sep 30, 2014
Assets
Cash
0
-57.4%
0
0
0
0
Cash and investments
0
-57.4%
0
0
0
0
Total current assets
0
-33.3%
0
0
0
0
Property and equipment, net
0
0
0
0
0
Total assets
1
-1.8%
1
1
1
1
Liabilities and equity
Accounts payable
1
-3.4%
1
1
1
1
Total current liabilities
5
-13.4%
6
6
6
6
Stockholders' equity
-4
+16.0%
-5
-5
-5
-5
Ratios
Current ratio
0.01x
0.01x
0.02x
0.04x
0.01x
Return on assets
-384.79%
—
—
-467.80%
—
Book value per share
-0.04
-0.06
-0.08
-0.10
-0.17
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BIOM (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Miami, FL
SEC filer status
Smaller reporting company
SEC CIK
1091326
Former names
SB Technology Holdings, Inc. (until May 4, 2026); VG Life Sciences Inc. (until Mar 6, 2026); VG Life Sciences, Inc. (until Oct 14, 2014); VIRAL GENETICS INC /DE/ (until Mar 25, 2009); 5 STARLIVING ONLINE INC (until Oct 18, 2001)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.